Moderna stock rises by over 90% due to the expected success of phase III trials for mRNA cancer vaccine
2026-08-19 20:47:08
According to CoinMeta, Moderna stock rose by over 90% in pre-market trading due to the success of the first phase three clinical trials of its mRNA cancer vaccine.
Source:Crypto Briefing
This content is for market information only and does not constitute investment advice.
Follow HQYC official accounts to stay updated

Hot Articles
Refresh

'No longer a distant place': F2Pool Co-founder Chun Wang joins SpaceX's 2-year mission to Mars
05-22 18:25

Polymarket Targets Japan Approval Despite Gambling Laws
05-22 18:00

ZachXBT flags suspected exploit involving Polymarket's UMA adapter contract on Polygon
05-22 17:57

ZachXBT flags $520K Polymarket exploit on Polygon, team says funds are safe
05-22 17:24

Verus bridge exploiter returns 4,052 ETH, retains $2.8 million bounty: onchain analyst
05-22 17:24



